Fadi Nahab

ORCID: 0000-0003-1710-9881
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Stroke Rehabilitation and Recovery
  • Long-Term Effects of COVID-19
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 and healthcare impacts
  • Intracranial Aneurysms: Treatment and Complications
  • Renal and Vascular Pathologies
  • Traumatic Brain Injury and Neurovascular Disturbances
  • COVID-19 Clinical Research Studies
  • Retinal and Optic Conditions
  • Cardiovascular and Diving-Related Complications
  • Congenital Heart Disease Studies
  • Neurological Disorders and Treatments
  • Peripheral Artery Disease Management
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Infrared Thermography in Medicine
  • Advanced MRI Techniques and Applications
  • Cerebral Venous Sinus Thrombosis
  • Advanced Neuroimaging Techniques and Applications
  • Retinal Imaging and Analysis
  • Neurological Disease Mechanisms and Treatments

Emory University
2016-2025

Emory University Hospital
2013-2025

Emory Healthcare
2014-2025

Kennesaw State University
2025

Arcadia
2024

Boston Medical Center
2021-2022

Boston University
2010-2022

Grady Memorial Hospital
2013-2022

Brookhaven College
2022

Hospital de Clínicas de Porto Alegre
2021

Raul G Nogueira Mohamad Abdalkader Muhammed M. Qureshi Michael Frankel Malek Mansour and 95 more Hiroshi Yamagami Zhongming Qiu Mehdi Farhoudi James E. Siegler Shadi Yaghi Eytan Raz Nobuyuki Sakai Nobuyuki Ohara Michel Piotin Laura Mechtouff Omer Eker Vanessa Chalumeau Timothy Kleinig Raoul Pop Jianmin Liu Hugh Stephen Winters Xianjin Shang Alejandro Rodriguez Vasquez Jordi Blasco Juan F. Arenillas Mario Martínez‐Galdámez Alex Brehm Marios‐Nikos Psychogios Pedro Lylyk Diogo C Haussen Alhamza R Al‐Bayati Mahmoud Mohammaden Luísa Fonseca M Luís Silva F. Mont’alverne Leonardo Renieri Salvatore Mangiafico Urs Fischer Jan Gralla Donald Frei Chandril Chugh Brijesh Mehta Simon Nagel Markus Möhlenbruch Santiago Ortega‐Gutiérrez Mudassir Farooqui Ameer E Hassan Allan Taylor Bertrand Lapergue Arturo Consoli Bruce Campbell Malveeka Sharma Melanie Walker Noel van Horn Jens Fiehler Huy Thang Nguyen Nguyễn Quốc Trung Daisuke Watanabe Hao Zhang Huynh Vu Le Viet Q. Nguyen Ruchir Shah Thomas Devlin Priyank Khandelwal Italo Linfante Wazim Izzath Pablo M. Lavados Verónica V. Olavarría Gisele Sampaio Silva Anna Verena de Carvalho Sousa Jawad F. Kirmani Martin Bendszus Tatsuo Amano Ryoo Yamamoto Ryosuke Doijiri Naoki Tokuda Takehiro Yamada Tadashi Terasaki Yukako Yazawa Jane G. Morris Emma Griffin John Thornton Pascale Lavoie Charles Matouk Michael D. Hill Andrew M. Demchuk Monika Killer‐Oberpfalzer Fadi Nahab Dorothea Altschul Anna Ramos‐Pachón Natàlia Pérez de la Ossa Raghid Kikano William Boisseau Gregory Walker Steve M Cordina Ajit S Puri Anna Luisa Kühn Dheeraj Gandhi Pankajavalli Ramakrishnan Roberta Novakovic‐White

The COVID-19 pandemic led to profound changes in the organization of health care systems worldwide.We sought measure global impact on volumes for mechanical thrombectomy, stroke, and intracranial hemorrhage hospitalizations over a three-month period at height (1 March-31 May 2020) compared with two control periods (immediately preceding one year prior).Retrospective, observational, international study, across 6 continents, 40 countries, 187 comprehensive stroke centers. diagnoses were...

10.1177/1747493021991652 article EN cc-by International Journal of Stroke 2021-01-18
Hooman Kamel W. T. Longstreth David Tirschwell Richard A. Kronmal Randolph S. Marshall and 95 more Joseph P. Broderick Rebeca Aragón García Pamela Plummer Noor Sabagha Qi Pauls Christy Cassarly Catherine Dillon Marco R. Di Tullio Eldad A. Hod Elsayed Z. Soliman David J. Gladstone Jeff S. Healey Mukul Sharma Seemant Chaturvedi L. Scott Janis Balaji Krishnaiah Fadi Nahab Scott E. Kasner Robert J. Stanton Dawn Kleindorfer Matthew Starr Danilo Toni Wayne M. Clark Benjamin Miller Mitchell S.V. Elkind Ganesh Asaithambi Maxwell Klaiman Konark Malhotra Mary Fetter Anna Wanahita Stacie Merritt Rehan Sajjad Kate McPolin Bruce M. Coull Shriya Kavathia Murali Kolikonda S Calhoun Felipe De Los Rios La Rosa Ian Del Conde Josette Elysée Amin Aghaebrahim Melissa Stratoberdha Andria L. Ford James Giles Yan Wang Jennifer Babka Rahul Damani Barbara Gutierrez-Flores Sandeep Kumar Sarah Marchina Marc Swerdloff Margaret Scott Amandeep Sangha Kelly Patterson Julie Shulman Steven K. Feske José R. Romero Hugo J. Aparicio David M. Greer Rebecca Stafford Arturo Tamayo Leanne Anderson Stelios M. Smirnakis Quinn Rademaker Maurice Hourihane Robert G. Sawyer Marilou Ching Amit Kandel Rakesh Magun Annemarie Crumlish Annaliese Bosco Sanjay Singh Abhishek Singh Elizabeth Traynor Ram Mohan Sankaraneni Toufik Mahfood Haddad Carly C. Isder L. Larsen Rasmussen Dustin Rochestie Nancy Brunetti Dhruvil J. Pandya Rosemarie R. Baligod Dan J. Capampangan Allegra Sahelian Jason T. Nomura Kimberly Gannon Jonathan Raser-Schramm Kathleen Murphy Ahmed Itrat Debra Hudock Dolora Wisco Laura Sweeney William Likosky Rebekah Garcia H Schumacher

Importance Atrial cardiopathy is associated with stroke in the absence of clinically apparent atrial fibrillation. It unknown whether anticoagulation, which has proven benefit fibrillation, prevents patients and no Objective To compare anticoagulation vs antiplatelet therapy for secondary prevention cryptogenic evidence cardiopathy. Design, Setting, Participants Multicenter, double-blind, phase 3 randomized clinical trial 1015 participants cardiopathy, defined as P-wave terminal force...

10.1001/jama.2023.27188 article EN JAMA 2024-02-07

<h3>Objective:</h3> We sought to determine the relationship of greater adherence Mediterranean diet (MeD) and likelihood incident cognitive impairment (ICI) evaluate interaction race vascular risk factors. <h3>Methods:</h3> A prospective, population-based, cohort individuals enrolled in Reasons for Geographic Racial Differences Stroke (REGARDS) Study 2003–2007, excluding participants with history stroke, impaired status at baseline, missing data on Food Frequency Questionnaires (FFQ), was...

10.1212/wnl.0b013e3182904f69 article EN Neurology 2013-04-29

Recent studies have reported that CRP levels are elevated in patients with COVID-19 and may correlate severity of disease progression. We conducted a retrospective cohort analysis the medical records 268 adult patients, who were admitted to one six cohorted COVID ICUs across Emory Healthcare System had at least two values within first seven days admission study temporal progression its association all-cause in-hospital mortality. The median during hospitalization for entire was 130 mg/L (IQR...

10.1371/journal.pone.0242400 article EN cc-by PLoS ONE 2020-11-20

Modified Rankin Scale (mRS) score 0-2 has been used to define "good outcome" while stroke patients with mRS 3 are grouped 4-6 as having "poor outcome." Long-term data comparing quality of life (QoL), particularly across the 2, 3, and 4 subgroups, sparse.Participants in Interventional Management Stroke (IMS3) trial documented 3-month mRS, functional disability (Barthel index [BI]), self-reported EQ5D-3L QoL questionnaires at months after were included. summary indices calculated using...

10.1159/000452634 article EN Interventional Neurology 2016-11-16

The pandemic caused by the novel coronavirus disease 2019 (COVID-19) has led to an unprecedented paradigm shift in medical care. We sought evaluate whether COVID-19 may have contributed delays acute stroke management at comprehensive centers.Pooled clinical data of consecutive adult patients from 14 US centers (January 1, 2019, July 31, 2020) were queried. rate thrombolysis for nontransferred within Target: Stroke goal 60 minutes was compared between admitted March and (pre-COVID-19), 2020,...

10.1161/strokeaha.120.032789 article EN mit Stroke 2020-11-30

Coronavirus disease 2019 (COVID-19) is associated with a small but clinically significant risk of stroke, the cause which frequently cryptogenic. In large multinational cohort consecutive COVID-19 patients we evaluated clinical predictors cryptogenic short-term functional outcomes and in-hospital mortality among according to stroke etiology.We explored characteristics consecutively 18 years age or older acute ischemic (AIS) laboratory-confirmed from 31 hospitals in 4 countries...

10.1186/s12883-021-02075-1 article EN cc-by BMC Neurology 2021-01-29

Background. There is an increase in the incidence of type 2 diabetes children and adolescents. Absence known autoimmune markers sometimes required to confirm diagnosis. Objective. To identify clinical characteristics a pediatric population. Method. We report analysis 48 adolescents with diabetes, compared 39 randomly selected 1 diagnosed followed at Loma Linda University Pediatric Diabetes Center. Ethnic, familial, seasonal, marker are outlined. determine reliability antibody testing...

10.1542/peds.107.6.e102 article EN PEDIATRICS 2001-06-01

There are limited data on the relationship between patient and site characteristics clinical outcomes after intracranial stenting.We performed a multivariable analysis that correlated with occurrence of primary endpoint (any stroke or death within 30 days stenting in territory stented artery beyond days) 160 patients enrolled this registry. All presented an ischemic stroke, TIA, other cerebral event (e.g., vertebrobasilar insufficiency) suspected 50-99% stenosis major while antithrombotic...

10.1212/01.wnl.0b013e3181a1863c article EN Neurology 2009-03-19

The European Cooperative Acute Stroke Study (ECASS) III extended the thrombolysis time window for patients with stroke from 3 to 4.5 hours after symptom onset. We investigated effect of on proportion recombinant tissue-type plasminogen activator-treated and treatment initiation hospital arrival.The present study was based a prospective database 93 hospitals Register Northwestern Germany, which included 91 805 ischemic admitted between January 2007 December 2009. Main outcome measures were...

10.1159/000438775 article EN Interventional Neurology 2015-01-01

The coronavirus disease (COVID-19) pandemic has threatened millions of lives worldwide with severe systemic inflammation, organ dysfunction, and thromboembolic disease. Within our institution, many critically ill COVID-19-positive patients suffered major thrombotic events, prompting clinicians to evaluate hypercoagulability outside traditional coagulation testing.We determined the prevalence fibrinolysis shutdown via rotational thromboelastometry (ROTEM, Instrumentation Laboratories,...

10.1097/shk.0000000000001635 article EN Shock 2020-08-04

To analyse the clinical characteristics of COVID-19 with acute ischaemic stroke (AIS) and identify factors predicting functional outcome.Multicentre retrospective cohort study patients AIS who presented to 30 centres in USA Canada between 14 March August 2020. The primary endpoint was poor outcome, defined as a modified Rankin Scale (mRS) 5 or 6 at discharge. Secondary endpoints include favourable outcome (mRS ≤2) mortality discharge, ordinal mRS (shift analysis), symptomatic intracranial...

10.1136/jnnp-2021-328354 article EN Journal of Neurology Neurosurgery & Psychiatry 2022-01-25

<h3>BACKGROUND AND PURPOSE:</h3> Treatment strategies in acute ischemic stroke aim to curtail progression. Emerging paradigms propose patient subselection using imaging biomarkers derived from CT, CTA, and CT perfusion. We evaluated the performance of a fully-automated computational tool, hypothesizing enhancements compared with qualitative approaches. The correlation between variables clinical outcomes cohort patients is reported. <h3>MATERIALS METHODS:</h3> Sixty-two MCA or ICA occlusion...

10.3174/ajnr.a4363 article EN cc-by American Journal of Neuroradiology 2015-05-21

Abstract Objective The objective of the present study was to examine relationship dietary fried fish consumption and risk cardiovascular events all-cause mortality. Design Prospective cohort among participants REasons for Geographic And Racial Differences in Stroke (REGARDS) who resided USA. Setting primary outcome measures included hazard ratios (HR) incident CVD including first fatal or non-fatal ischaemic stroke myocardial infarction mortality, based on cumulative average ascertained at...

10.1017/s136898001600152x article EN Public Health Nutrition 2016-06-24

There are limited data on the prevalence and prognosis of asymptomatic intracranial stenosis (AIS). Baseline cerebral angiograms MR were used to determine AIS (50% 99%) coexistent symptomatic for patients enrolled in Warfarin-Aspirin Symptomatic Intracranial Disease study. Coexisting detected 18.9% (n=14/74) undergoing 4-vessel angiography 27.3% (n=65/238) angiogram. During a mean follow-up period 1.8 years, no ischemic strokes attributable an 5 (5.9%, 95% CI: 2.1% 12.3%) occurred territory...

10.1161/strokeaha.107.499475 article EN Stroke 2008-02-01

Pretreatment Alberta Stroke Program Early CT Scores (ASPECTS) is associated with clinical outcomes. The rate of decline between subsequent images, however, may be more predictive outcomes as it integrates time and physiology.A cohort patients transferred from six primary stroke centers treated intra-arterial therapy (IAT) was retrospectively studied. Absolute ASPECTS decay defined ((ASPECTS First CT-ASPECTS Second CT)/hours elapsed images). A logistic regression model performed to determine...

10.1136/neurintsurg-2013-011048 article EN Journal of NeuroInterventional Surgery 2014-01-17

Clopidogrel is an antiplatelet drug that metabolized to its active form by the CYP2C19 enzyme. The CHANCE trial (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) found a significant interaction between loss-of-function allele status for gene and effect of dual therapy with aspirin clopidogrel on rate early recurrent stroke following acute transient ischemic attack/minor stroke. POINT (Platelet-Oriented Inhibition New TIA Minor Ischemic Stroke Trial), similar...

10.1161/strokeaha.119.028713 article EN Stroke 2020-06-17

In the setting of Coronavirus Disease 2019 (COVID-19) global pandemic caused by SARS-CoV-2, a potential association this disease with stroke has been suggested. We aimed to describe characteristics patients who were admitted COVID-19 and had an acute ischemic (AIS).This is case series PCR-confirmed academic health system in metropolitan Atlanta, Georgia (USA) between March 24th, 2020 July 17th, 2020. Demographic, clinical, radiographic described.Of 396 during study period, 13 (2.5%) also...

10.1371/journal.pone.0239443 article EN cc-by PLoS ONE 2020-09-18

Background There is limited data on the markers of coagulation and hemostatic activation (MOCHA) profile in Coronavirus disease 2019 (COVID-19) its ability to identify COVID-19 patients at risk for thrombotic events other complications. Methods Hospitalized with confirmed SARS-COV-2 from four Atlanta hospitals were included this observational cohort study underwent admission testing MOCHA parameters (plasma d-dimer, prothrombin fragment 1.2, thrombin-antithrombin complex, fibrin monomer)....

10.1371/journal.pone.0248230 article EN cc-by PLoS ONE 2021-03-19
Coming Soon ...